Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 201-225 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Evaluation the Efficacy and Safety of Tocilizumab in Patients with Novel Coronavirus (COVID-19)
Design:
Non-controlled clinical trial
Settings and conduct:
Dr. Masih Daneshvari Hospital
Participants/Inclusion and exclusion criteria:
Patients with confirmed COVID-19 who are in severe phase and did
COVID-19 in the initial phase who have referred to the Infectious Diseases Clinic of Baqiyatallah (...) :
Inclusion criteria: having a patient in the family; Positive COVID-19 PCR test; Onset of clinical symptoms (...) antiviral drugs; thrombocytopenia; receiving recent vaccination of COVID-19
Intervention groups
severe COVID-19 patients.
Design:
Concealed, randomized, single blinded, phase 3 controlled clinical (...) . (single blinded)
Participants/Inclusion and exclusion criteria:
All COVID-19 patients admitted to the (...) A, the standard treatment for COVID-19 patients with N-Acetylcysteine is prescribed. In group B
patients with mild to moderate COVID-19
Design:
Randomised control trial (stratified randomisation based (...) .
Settings and conduct:
Patients with mild to moderate COVID-19 symptoms with positive PCR test for COVID-19(...) to moderate COVID-19 symptoms (according to the national guidance definitions) with a positive PCR
treatment of patients with severe covid19 infection (COVID-19)
Design:
Clinical evaluation has a parallel (...) and medication outside the standard COVID19 treatment protocol, and the physician believes that the (...) mg per kg body weight (1-3 mg / kg / d) for 2–4 days
2) Receive basic COVID-19 treatment based on the
with severe SARS-CoV-2 infection (COVID-19)
Design:
Randomized, parallel-controlled group, multi (...) specialists.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Laboratory confirmed COVID-19(...) immediately life-threatening COVID-19. Non-inclusion criteria: Those who have history of allergy to blood
severe COVID-19
Design:
This double blind clinical trial has two intervention and control groups, which (...) .
Settings and conduct:
Hospitalized patients with COVID-19 will be divided into 2 groups by permuted block (...)
- Positive PCR test for COVID-19 or evidence against the disease
- Patients with moderate to severe disease
Study aim:
Determining the effect of Colchicine on the recovery of patients with COVID-19 in the (...) mechanically ventilated patients of COVID-19
Design:
Clinical trial with a control group, having parallel (...) located in Qom, by randomly selecting patients COVID-19 to be placed in the intervention and control
of patients with COVID-19
Design:
Study with a control group, community-based and pragmatic, with a (...) exclusion criteria:
Patient inclusion criteria: Diagnosis of COVID-19. Caregiver conditions: be a first (...) another person; no hearing problems; age 18 to 70 years old; no family history of death due to COVID-19
Study aim:
Evaluation of low dose whole lung irradiation for treatment of resistant COVID-19(...) criteria:
Inclusion criteria: male patients older than 60, diagnosis of COVID-19 based on PCR or imaging (...) supplemental oxygen), obvious COVID-19 pulmonary patterns on chest CT, severe or refractory lung disease
Study aim:
Reducing in mortality and improve oxygenation in covid-19 patient's
Design:
covid-19patients admitted to the intensive care unit and who had severe respiratory failure and lack of adequate (...) exclusion criteria:
patient's admited in ICU and wards
Intervention groups:
covid-19patients admitted to
with Covid19
Design:
A clinical trial with a control group, with parallel groups, one-way blind (...) :
This single-blind clinical trial study will be performed on patients with COVID-19 who are being (...)Covid19 by an infectious disease specialist and hospitalized in the ward, the patient is over 18 years
Study aim:
This study aimed to determine the effects of Elman tablet on illness severity and length of hospital stay patients with Covid-19 infection.
Design:
This study is a three-group clinical (...) exclusion criteria:
inclusion criteria: Patients diagnosed with COVID-19 disease based on PCR test and their
Covid-19
Design:
Clinical trial has acontrol group with parallel groups, this study was open label due (...) group, patients receive all available treatments for Covid-19 according to the latest treatment (...) /Inclusion and exclusion criteria:
Inclusion criteria:
Patients with Covid-19 whose diagnosis is confirmed by
colloidal solution containing 4-5% albumin, fresh frozen plasma, and convalescent plasma in COVID-19(...) will be done on 10 patients with CoVID-19
Settings and conduct:
This study will conduct on patients with COVID- 19 who admitted in the Taleghani hospital of Tehran. Approximately 1500-2000 milliliter of
treatment of hospitalized patients with COVID-19.
Design:
A two-arm, parallel, randomized, open-label, controlled clinical trial on 60 hospitalized COVID-19 patients. Random blocks will be used for randomization.
Settings and conduct:
This study will be performed on hospitalized COVID-19 patients in Ayatollah Rouhani
Study aim:
Evaluation of the effectiveness of dexmedetomidine in sedation of COVID-19 critically (...) or intervention groups.Sixty critically ill patients of Covid-19 will be divided into two groups of (...) standard Covid-19 drug therapy including remedicivir, interferon, and corticosteroids, and supplements in
Study aim:
Determining of adding SOVODAK (sofosbuvir + daclatasvir) to the treatment protocol of COVID-19 outpatients: A Clinical Trial Study
Design:
A clinical trial study will have a control group (...) criteria:
Inclusion Criteria: Patients with Quaid 19 confirmed by CT scan findings
Exclusion criteria
: pregnant or lactating people, who had positive Ig G or Ig M antibody titers for Covid-19 at the beginning (...) Immunoglobulin M (Ig M) antibodies titers
Symptoms of COVID-19(...) Study aim:
Determining the efficacy of women's empowerment in predicting the consequences of COVID
Study aim:
Evaluating the efficacy of ivermectin in the treatment of COVID-19 patients
Design (...) study will performe on patients with severe COVID-19 patients admitted to Labbafinejad Hospital in 1401 (...) /Inclusion and exclusion criteria:
Inclusion criteria are: Laboratory confirmation of COVID-19 virus by RT
patients with severe COVID-19
Design:
Randomized open label clinical trial, with two arms with 1: 1 allocation ratio
Settings and conduct:
This study will perform on severe COVID-19 patients admitted to (...) : Laboratory confirmation of COVID-19 virus by PCR, severe cases according to the World Health Organization
doses of enoxaparin treatment in patients with severe COVID-19.
Design:
Two arm parallel group (...) .
Settings and conduct:
Severe Covid-19 patients were treated with the respective doses (based on allocated (...) .
Participants/Inclusion and exclusion criteria:
Patients over 18 years of age with an RT-PCR confirmed COVID-19
biomarkers of patients with COVID-19 admitted to hospital
Design:
Clinical trial with control group, with (...) of army .In this study, 160 newly diagnosed COVID-19 hospitalized patients are selected based on (...) criteria: 1. Non-pregnant and non-lactating women and men over 18 years with positive PCR for Covid-19
2
with COVID-19
Design:
68 patients between the ages of 18 and 75 with a probable diagnosis of COVID-19(...) patients who refer to Razi Hospital in Ghaemshahr are diagnosed with COVID-19 manifestation will entered. Then, 68 patients between the ages of 18 and 75 with a probable diagnosis of COVID-19 according to the